Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

18
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
18
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.5K
Relative Risk01:12

Relative Risk

2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.9K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.9K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

802
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
802
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

932
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
932

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The cured cancer patients].

Bulletin du cancer·2001
Same author

[Hippocrates' error].

Bulletin du cancer·2001
Same author

[Technology and humanism].

Bulletin du cancer·2001
Same author

[Hormonal replacement therapy and breast cancer].

Bulletin du cancer·1999
Same author

An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Annals of oncology : official journal of the European Society for Medical Oncology·1998
Same author

[Secondary non-Hodgkin's lymphomas].

Bulletin du cancer·1998
Same journal

[Diagnostic procedures in primary hyperparathyroidism].

Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille·1981
Same journal

[Changes in an institution after the creation of an open department].

Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille·1981
Same journal

[Do disorders of sexual orientation have a biological basis ?].

Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille·1981
Same journal

[Current fields of application of microsurgery. Round table].

Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille·1981
Same journal

[Pseudotumor cerebri caused by chronic vitamin A poisoning].

Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille·1981
Same journal

[Urinary free cortisol measured by protein radio-competition in normal subjects and in hypo- and hypercorticism].

Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille·1981
See all related articles

Related Experiment Video

Updated: Feb 16, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.5K

[Oncogenic risks in anticancer chemotherapy]

P Cappelaere

    Lille Medical : Journal De La Faculte De Medecine Et De Pharmacie De L'Universite De Lille
    |April 1, 1981
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Modeling Chemotherapy Resistant Leukemia In Vitro
    08:41

    Modeling Chemotherapy Resistant Leukemia In Vitro

    Published on: February 9, 2016

    9.6K
    Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
    07:42

    Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

    Published on: April 26, 2012

    18.6K

    Related Experiment Videos

    Last Updated: Feb 16, 2026

    Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
    08:03

    Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

    Published on: December 1, 2016

    9.5K
    Modeling Chemotherapy Resistant Leukemia In Vitro
    08:41

    Modeling Chemotherapy Resistant Leukemia In Vitro

    Published on: February 9, 2016

    9.6K
    Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
    07:42

    Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity

    Published on: April 26, 2012

    18.6K